Dec. 16 (UPI) -- A Centers for Disease Control and Prevention advisory panel said Thursday that it prefers COVID-19 vaccines made by Moderna and Pfizer over one made by Johnson & Johnson due to rare blood clotting problems reported with the latter.
The Advisory Committee on Immunization Practices voted unanimously to recommend the two two-shot vaccines over Johnson & Johnson's single-dose immunization.